Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Judit Joergensen"'
Autor:
Robert Manges, Javier Munoz, Neus Domper, Jeanna Knoble, Ulrich Jäger, Grzegorz S. Nowakowski, Nagesh Kalakonda, Lorenz Trümper, Judit Joergensen, Richard Greil, Wolfgang Willenbacher, Thomas Stauffer Larsen, Oliver Manzke, Krish Patel, David Cunningham, Hele Everaus, Marie-Laure Casadebaig, Peter de Nully Brown, Corinne Haioun
Publikováno v:
Journal of Clinical Oncology. 37:7520-7520
7520 Background: We report results of a phase 2, open-label study of durvalumab (durva) in combination with R-CHOP or R2-CHOP (R-CHOP + lenalidomide) in previously untreated, high-risk diffuse large B-cell lymphoma (DLBCL). Methods: Subjects (≥18 y
Autor:
Peter Meyer, Unn-Merete Fagerli, L. M. Pedersen, Judit Joergensen, Kaija Vasala, Sirkku Jyrkkiö, Øystein Fluge, Lars Munksgaard, Mats Jerkeman, Mikael Eriksson, Peter de Nully Brown, Thomas Stauffer Larsen, Martin Maisenhölder, Sirpa Leppä, Harald Holte, R. Janes, S. Mannisto, Magnus Björkholm
Publikováno v:
Leppa, S, Joergensen, J, Brown, P D N, Fagerli, U, Larsen, T S, Janes, R, Mannisto, S, Munksgaard, L, Maisenhölder, M, Vasala, K, Meyer, P, Jerkeman, M, Björkholm, M, Fluge, Ø, Jyrkkiö, S, Pedersen, L M, Eriksson, M & Holte, H 2017, ' Dose-dense chemoimmunotherapy and CNS prophylaxis in patients with high-risk DLBCL : a comparison of Nordic CRY-04 and CHIC studies ', Hematological Oncology
, vol. 35, no. S2, pp. 199–200 . https://doi.org/10.1002/hon.2438_62
Leppa, S, Joergensen, J, Brown, P, Fagerli, U, Larsen, T S, Janes, R, Mannisto, S, Munksgaard, L, Maisenhölder, M, Vasala, K, Meyer, P, Jerkeman, M, Björkholm, M, Fluge, Ø, Jyrkkiö, S, Pedersen, L M, Eriksson, M & Holte, H 2017, ' Dose-dense chemoimmunotherapy and CNS prophylaxis in patients with high-risk DLBCL: a comparison of Nordic CRY-04 and CHIC studies ', ICML-14, Lugano, Schweiz, 14/06/2017-17/06/2017 .
, vol. 35, no. S2, pp. 199–200 . https://doi.org/10.1002/hon.2438_62
Leppa, S, Joergensen, J, Brown, P, Fagerli, U, Larsen, T S, Janes, R, Mannisto, S, Munksgaard, L, Maisenhölder, M, Vasala, K, Meyer, P, Jerkeman, M, Björkholm, M, Fluge, Ø, Jyrkkiö, S, Pedersen, L M, Eriksson, M & Holte, H 2017, ' Dose-dense chemoimmunotherapy and CNS prophylaxis in patients with high-risk DLBCL: a comparison of Nordic CRY-04 and CHIC studies ', ICML-14, Lugano, Schweiz, 14/06/2017-17/06/2017 .
Autor:
Signe Spetalen, Sirkku Jyrkkiö, Elisabeth Ralfkiaer, Ingunn Østlie, Øystein Fluge, Sirpa Leppä, Judit Joergensen, Unn-Merete Fagerli, Harald Holte, Peter Meyer, Mats Jerkeman, Kaija Vasala, Marja-Liisa Karjalainen-Lindsberg, Lars Munksgaard, Martin Maisenhölder, Anne Tierens, Susanna Mannisto, Peter de Nully Brown, Thomas Stauffer Larsen, Magnus Björkholm
Publikováno v:
University of Helsinki
Introduction: Survival of patients with high-risk diffuse large B-cell lymphoma (DLBCL) is suboptimal, and the risk of early central nervous system (CNS) progression is high. Here we present the final results from a Nordic phase II study, where dose-
Autor:
Michael Thorsgaard, Peter Kamper, Lars C. Gormsen, Trine Silkjaer, Ida Blok Sillesen, Francesco d'Amore, Erik Segel, Helle Toldbod, Bjarne Bach Pedersen, Sirpa Leppä, Hans Bentzen, Michael Roost Clausen, Elisa Jacobsen Pulczynski, Judit Joergensen, Dorte Balle Gillström
Publikováno v:
University of Helsinki
Background: With currently available therapies, relapsed/refractory aggressive non-Hodgkin lymphoma (NHL) after high-dose therapy or, in not transplant-eligible patients, after first-line chemotherapy represents an unequivocally unmet clinical need.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c133afd0c0072c83c6d3f31a111ae06
https://researchportal.helsinki.fi/en/publications/1df4da8d-1b74-4aa8-9ca4-1cce94fba7ec
https://researchportal.helsinki.fi/en/publications/1df4da8d-1b74-4aa8-9ca4-1cce94fba7ec